XML 29 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2011
Stock-Based Compensation  
Stock-based compensation cost included in Consolidated Statement of Earnings

 

($ in millions)

 

 

 

 

 

 

 

 

 

For the year ended December 31:

 

2011

 

2010

 

2009

 

Cost

 

$

120

 

$

94

 

$

94

 

Selling, general and administrative

 

514

 

488

 

417

 

Research, development and engineering

 

62

 

48

 

47

 

Other (income) and expense*

 

 

(1

)

 

Pre-tax stock-based compensation cost

 

697

 

629

 

558

 

Income tax benefits

 

(246

)

(240

)

(221

)

Total stock-based compensation cost

 

$

450

 

$

389

 

$

337

 

 

* Reflects the one-time effects of the sale of the Product Lifecycle Management activities.

 

Summary of option activity

 

 

 

2011

 

2010

 

2009

 

 

 

Weighted
Average
Exercise Price

 

Number of
Shares
Under Option

 

Weighted
Average
Exercise Price

 

Number of
Shares
Under Option

 

Weighted
Average
Exercise Price

 

Number of
Shares
Under Option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1

 

$

94

 

39,197,728

 

$

98

 

73,210,457

 

$

102

 

119,307,170

 

Options exercised

 

98

 

(18,144,309

)

101

 

(33,078,316

)

98

 

(28,100,192

)

Options canceled/expired

 

107

 

(391,097

)

108

 

(934,413

)

127

 

(17,996,521

)

Balance at December 31

 

$

90

 

20,662,322

 

$

94

 

39,197,728

 

$

98

 

73,210,457

 

Exercisable at December 31

 

$

90

 

20,662,322

 

$

94

 

39,197,728

 

$

98

 

72,217,126

 

 

Options outstanding and exercisable with exercise price ranges

 

 

 

Options Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

Weighted

 

Number of

 

Aggregate

 

Remaining

 

 

 

Average

 

Shares

 

Intrinsic

 

Contractual Life

 

Exercise Price Range

 

Exercise Price

 

Under Option

 

Value

 

(in Years)

 

$61–$85

 

$

78

 

8,079,175

 

$

857,827,574

 

1.3

 

$86–$105

 

97

 

11,061,890

 

957,308,722

 

2.6

 

$106 and over

 

106

 

1,521,257

 

118,474,466

 

2.0

 

 

 

$

90

 

20,662,322

 

$

1,933,610,763

 

2.1

 

Summary of Restricted Stock Units activity

 

 

 

2011

 

2010

 

2009

 

 

 

Weighted

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

 

Average

 

Number

 

Average

 

Number

 

Average

 

Number

 

 

 

Grant Price

 

of Units

 

Grant Price

 

of Units

 

Grant Price

 

of Units

 

Balance at January 1

 

$

110

 

11,196,446

 

$

102

 

13,405,654

 

$

100

 

12,397,515

 

RSUs granted

 

154

 

5,196,802

 

122

 

3,459,303

 

105

 

4,432,449

 

RSUs released

 

106

 

(3,508,700

)

98

 

(5,102,951

)

99

 

(2,748,613

)

RSUs canceled/forfeited

 

122

 

(665,947

)

105

 

(565,560

)

101

 

(675,697

)

Balance at December 31

 

$

129

 

12,218,601

 

$

110

 

11,196,446

 

$

102

 

13,405,654

 

 

Summary of Performance Share Units activity

 

 

 

2011

 

2010

 

2009

 

 

 

Weighted

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

 

Average

 

Number

 

Average

 

Number

 

Average

 

Number

 

 

 

Grant Price

 

of Units

 

Grant Price

 

of Units

 

Grant Price

 

of Units

 

Balance at January 1

 

$

111

 

3,649,288

 

$

107

 

3,476,737

 

$

102

 

3,078,694

 

PSUs granted at target

 

154

 

1,055,687

 

117

 

1,239,468

 

101

 

1,568,129

 

Additional shares earned above target*

 

118

 

230,524

 

103

 

463,913

 

83

 

396,794

 

PSUs released

 

118

 

(1,189,765

)

103

 

(1,486,484

)

83

 

(1,440,099

)

PSUs canceled/forfeited

 

118

 

(58,743

)

108

 

(44,346

)

111

 

(126,781

)

Balance at December 31**

 

$

122

 

3,686,991

 

$

111

 

3,649,288

 

$

107

 

3,476,737

 

 

*                 Represents additional shares issued to employees after vesting of PSUs because final performance metrics exceeded specified targets.

 

**          Represents the number of shares expected to be issued based on achievement of grant date performance targets. The actual number of shares issued depends on the company’s performance against specified targets over the vesting period.